Table 1

 Details of children at time of first BAL and of the whole group

ParametersFirst visit(N = 24)Total visits(N = 27)
C/T/S, cephalosporin/trimethoprim/sulfamethoxazole.
No of subjects2424
Median (IQR) age at first study1.58 (1.07–2.75)1.58 (1.12–2.77)
Sex12M (50%)14M (52%)
Genotype
    Homozygote17 (70.8%)19 (70.3%)
    Heterozygote78
    Compound heterozygote (not F508)11
No of visits2727
No of children with repeat visits33
Microbiology at time of visit
    No pathogen12 (48%)13 (48%)
    Mixed oral flora3 (12%)3 (12%)
    A fumigatus1 (4%)1 (4%)
    S aureus3 (12%)3 (12%)
    H influenzae1 (4%)2 (8%)
    P aeruginosa4 (16.7%)4 (15%)
    Enterobacter sp2 (8%)2 (8%)
    C albicans1 (4%)1 (4%)
    Other3 (12%)3 (12%)
Treatments at time of BAL
    No antibiotics6 (22.2%)
    Amoxycillin/clavulanate18 (66.7%)
    C/T/S3 (11.1%)